Xu, Chenqi

Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism

Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature

Cancer Immunotherapy and BiomarkersCancer, Lipids, and Metabolism

Cited by 1,010

FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells

Meng, X., Liu, X., Guo, X., Jiang, S., Chen, T., Hu, Z., Liu, H., Bai, Y., Xue, M., Hu, R., et al. (2018) · Nature

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 303

Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness

Chen, J., Qiu, S., Li, W., Wang, K., Zhang, Y., Yang, H., Liu, B., Li, G., Li, L., Chen, M., et al. (2023) · Cell Research

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 195

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Fan, Z., Tian, Y., Chen, Z., Liu, L., Zhou, Q., He, J., Coleman, J., Dong, C., Li, N., Huang, J., et al. (2020) · EMBO Molecular Medicine

Cancer Immunotherapy and BiomarkersProtein Tyrosine Phosphatases

Cited by 62

Disulfiram bolsters T‐cell anti‐tumor immunity through direct activation of LCK‐mediated TCR signaling

Wang, Q., Zhu, T., Miao, N., Qu, Y., Wang, Z., Chao, Y., Wang, J., Wu, W., Xu, X., Xu, C., et al. (2022) · The EMBO Journal

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 45